Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV (Q34637577)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Bente Klarlund Pedersen

7

object named as

Bente Klarlund Pedersen

0 references

Birgitte Lindegaard

object named as

Birgitte Lindegaard

1

0 references

5

object named as

Jan Gerstoft

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

object named as

Thine Hvid

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Pernille Hojman

6

object named as

Pernille Hojman

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Thomas Grøndahl

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Christian Frosig

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

22 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

e55632

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

22 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Fibroblast growth factor 21: from pharmacology to physiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

FGF21 is an Akt-regulated myokine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Fibroblast growth factor 21 corrects obesity in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

FGF-21 as a novel metabolic regulator

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Effects of fat on insulin-stimulated carbohydrate metabolism in normal men

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

7 July 2018

Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Alterations in liver, muscle, and adipose tissue insulin sensitivity in men with HIV infection and dyslipidemia.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Inhibition of Lipolysis Stimulates Peripheral Glucose Uptake but Has No Effect on Endogenous Glucose Production in HIV Lipodystrophy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Skeletal muscle insulin signaling defects downstream of phosphatidylinositol 3-kinase at the level of Akt are associated with impaired nonoxidative glucose disposal in HIV lipodystrophy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Mitochondrial myopathy induces a starvation-like response

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055632

21 January 2018

Fibroblast growth factor-21 protects human skeletal muscle myotubes from palmitate-induced insulin resistance by inhibiting stress kinase and NF-κB.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3606412

26 October 2018

A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose

1 reference

https://pubmed.ncbi.nlm.nih.gov/23533568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23533568

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0055632

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2013PLoSO...855632L

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34637577&oldid=2119218627"